MAbSilico sells a Software as a Service for antibodies drug discovery based on artificial intelligence technologies. Conventional approaches for drug discovery take up to three years, while MAbSilico technologies allow shrinking this time to a few weeks for all the pitfalls of the discovery pipeline (antibody selection, characterization and optimization). Our formal embedded technology secure and accelerate the drug discovery process.